Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study
The efficacy of MMF was similar to that of CYC in terms of response (6 months without steroids) in children with FR/SD nephrotic syndrome. MMF showed a favorable response in terms of the frequency of relapse and treatment failure. REGISTRATION OF THE STUDY WITH CLINICAL TRIALS REGISTRY OF INDIA: ( http://ctri.nic.in ;CTRI/2021/06/034421) (Dt: 28/06/2021).
Authors
- Shruti Kakkar (ORCID: https://orcid.org/0000-0001-8849-0072)
- Puneet A. Pooni (ORCID: https://orcid.org/0000-0001-6726-0788)
- Gurdeep Singh Dhooria (ORCID: https://orcid.org/0000-0002-4033-8693)
- Deepak Bhat (ORCID: https://orcid.org/0000-0001-9387-4951)
- Siddharth Bhargava (ORCID: https://orcid.org/0000-0002-7361-8560)
- Nancy Goel
Institutions
- Dayanand Medical College & Hospital (IN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1186/s12882-024-03739-z
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.02